Browse the evidence

Aging, estrogen deficiency, glucocorticoid treatment, and disuse stimulate the accumulation of intramyocellular lipid and intermuscular fat (myosteatosis), which is linked to loss of muscle strength, reduced insulin sensitivity, and increased mortality.

As you age, your muscles are prone to accumulating fat, which weakens them and increases your risk of falls. This process is driven by hormonal changes and lack of use. To counteract this, engage in regular resistance exercise or low-magnitude vibration to keep your muscle cells from turning into fat cells.

Dual-energy X-ray absorptiometry (DXA) is the preferred criterion measure for body composition assessment because it provides a multi-compartment model including bone mineral content, offering higher accuracy than two-compartment methods.

If you have access to DXA, use it for the most accurate baseline of bone, fat, and muscle. However, recognize that other methods like BIA or skinfolds are valid for tracking changes over time if DXA is not accessible.

Computed tomography (CT) assessment of muscle mass and myosteatosis lacks standardization across studies, with significant variation in anatomic landmarks, thresholding values, and reporting of technical parameters like contrast use and slice thickness.

When interpreting or conducting CT-based muscle assessments, ensure strict adherence to standardized protocols regarding anatomic landmarks (e.g., L3), thresholding values, and reporting of technical parameters (contrast, slice thickness). Lack of standardization currently limits the ability to compare results across studies or clinics.

Low insulin-stimulated glucose disposal (M) and low acute insulin secretory response (AIR) are independent and additive predictors of the progression from normal glucose tolerance (NGT) to impaired glucose tolerance (IGT) and from IGT to type 2 diabetes.

If you have normal or pre-diabetic blood sugar, your body's ability to use insulin (sensitivity) and its ability to release insulin quickly (secretion) are the two main levers determining if you develop diabetes. Both matter equally at every stage. Monitoring these metrics can help identify high-risk individuals for early intervention.

Upper body subcutaneous fat is the primary source of excess free fatty acid (FFA) release in upper body obesity, contributing more to systemic FFA levels and metabolic risk than visceral fat itself.

When addressing upper body obesity, recognize that subcutaneous fat in the abdominal area is a major contributor to metabolic issues by releasing fatty acids into the bloodstream. Strategies to improve metabolic health should consider this specific fat depot's behavior.

Elevated free fatty acid (FFA) delivery to the liver from visceral and upper body subcutaneous fat depots stimulates hepatic VLDL-triglyceride production, leading to hypertriglyceridemia and low HDL cholesterol, which are independent risk factors for cardiovascular disease.

High levels of fatty acids reaching the liver from abdominal fat stores drive the production of triglyceride-rich lipoproteins, increasing cardiovascular risk. Managing abdominal fat can help mitigate this risk.

Glucose and its metabolites (e.g., lactate, alanine, TCA intermediates) act as signaling molecules that communicate the metabolic status of peripheral tissues (muscle, adipose) to other organs (liver, hypothalamus) to maintain glucose homeostasis.

Your body uses the byproducts of glucose metabolism (like lactate and alanine) to talk to your liver and brain about your energy status. This 'intertissue communication' helps regulate blood sugar. Disruptions in this signaling, such as reduced glucose entry into fat cells, can lead to insulin resistance.

Weight-loss and bodybuilding supplements, particularly those containing ephedra, DMAA, or adulterated with unlisted drugs (e.g., anabolic steroids, fluoxetine), carry a significant risk of severe adverse events including liver failure, cardiovascular collapse, and death.

Avoid weight-loss supplements containing ephedra, DMAA, or unlisted ingredients. Bodybuilding supplements are frequently adulterated with steroids or other drugs. If you experience liver symptoms (jaundice, fatigue) or cardiovascular issues (palpitations, chest pain) after taking these, stop immediately and seek medical help. The risk of severe injury or death is real.

Black adults experience higher rates of short sleep and poor sleep quality compared to Whites, and this disparity is exacerbated by socioeconomic stressors and unique psychosocial stressors like 'John Henryism'.

If you are Black, you may face unique stressors that disrupt sleep. Recognize that your sleep difficulties may be linked to systemic stress and not just personal habits. Seek support for stress management and prioritize rest as a health necessity.

Pharmacological interventions for diabetes prevention are effective during active treatment but lose their efficacy immediately upon discontinuation, indicating they do not alter the underlying pathophysiology of insulin resistance or beta-cell dysfunction.

Medications can effectively prevent diabetes while you are taking them, but they do not provide long-term protection once you stop. If you discontinue medication, your risk returns to baseline. Therefore, medications are not a substitute for sustainable lifestyle changes if you plan to stop treatment.

Aging is associated with a significant increase in intramuscular noncontractile (fat) content and a decrease in contractile cross-sectional area, resulting in a >2-fold increase in fat relative to muscle mass in older adults compared to young adults.

As you age, your muscles naturally lose contractile tissue and gain fat, roughly doubling the fat content in your leg muscles. This is a primary driver of strength loss. While you cannot fully reverse aging, understanding this shift highlights why maintaining activity is critical for preserving muscle quality.

Postoperative Basic Metabolic Rate (BMR) decreases in proportion to weight loss after bariatric surgery, with no difference in BMR reduction between LGBP and LVBG, refuting the theory of postoperative hypermetabolism.

After bariatric surgery, your metabolic rate decreases as expected with your weight loss. There is no 'hypermetabolic' state that drives weight loss; instead, the reduction in energy expenditure is proportional to the loss of body mass.

Bone Mineral Density (BMD) is an imperfect predictor of fracture risk because it fails to account for bone size, geometry, quality, and turnover rates, leading to potential misinterpretation of intervention efficacy.

Do not rely solely on BMD (DXA scan) results to determine your fracture risk or the success of your treatment. Bone strength involves geometry, quality, and fall risk. Focus on overall bone health strategies (nutrition, exercise, fall prevention) rather than just trying to 'raise your number'.

In healthy individuals, chronological age itself does not cause insulin resistance; observed declines in insulin sensitivity with age are fully explained by age-related increases in body mass index (BMI) and fat mass.

Do not accept insulin resistance as an inevitable part of aging. This study shows that in healthy people, the decline in insulin sensitivity is actually driven by gaining weight (specifically fat mass) and changes in body composition, not age itself. Focus on maintaining a healthy BMI and body composition rather than blaming your age for metabolic changes.

In lean women, insulin action declines with age specifically due to impaired suppression of free fatty acids (FFAs), which leads to substrate competition where FFAs are oxidized instead of glucose.

If you are a lean woman, be aware that your insulin sensitivity may decline with age due to how your body handles fat acids, not just weight gain. This is a specific biological mechanism (substrate competition) rather than just 'getting old'. Monitoring body composition and metabolic health is important even if your BMI remains low.

Peripheral nutrient sensing mechanisms (taste, gut hormones like GLP-1, PYY, CCK, and signals from adipose tissue like leptin) provide critical feedback to the brain to regulate food intake and energy expenditure.

Understanding that hormones like GLP-1, PYY, and leptin signal satiety and energy status can help explain why certain foods (high fat/protein) trigger stronger satiety signals than others. Prioritizing foods that naturally stimulate these peripheral sensors (e.g., protein, fiber) may support natural homeostatic regulation.

Hypothalamic integration of nutritional information via neuropeptides (NPY/AgRP and POMC/CART) and molecular sensors (AMPK, mTOR) is a critical hub for regulating energy balance, with genetic defects in these pathways causing severe obesity.

Genetic factors play a significant role in how the brain regulates hunger and satiety. For some, this regulation is impaired due to genetic defects (e.g., MC4R deficiency). This highlights that obesity is not always a simple lifestyle choice but can have strong biological underpinnings.

Adenosine acts as a primary sleep-promoting factor by inhibiting wake-active cholinergic neurons in the basal forebrain via A1 receptors and stimulating sleep-active neurons in the ventrolateral preoptic area (VLPO) via A2 receptors, with extracellular concentrations increasing during wakefulness and decreasing during sleep.

Your brain naturally produces adenosine during wakefulness, which builds up to create sleep pressure. This process is mediated by specific receptors in the basal forebrain and VLPO. While caffeine blocks this signal to keep you awake, understanding this mechanism explains why sleep deprivation leads to higher adenosine levels and why sleep is necessary to clear it.

Gastric distension and gut hormones (CCK, GLP-1, PYY) are the primary physiological mechanisms for satiation and satiety, but these signals can be overridden by hedonic and external factors.

Understand that your body has sophisticated satiety signals (gastric distension, CCK, GLP-1, PYY) that work to stop eating. However, in an environment with highly palatable, energy-dense foods, these signals are often overridden by reward pathways. To manage weight, you must account for this override by controlling portion sizes and food availability, rather than relying solely on internal fullness cues.

Adiposity signals, specifically leptin and insulin, act as afferent information to the brain to regulate long-term body fat levels by modulating the sensitivity of meal-terminating signals.

Your body uses leptin and insulin to tell your brain how much fat you have. When you lose weight, these signals drop, making you less sensitive to fullness cues and driving you to eat more. This is a biological defense mechanism, not a character flaw. Recognizing this helps reduce guilt and allows for more sustainable, long-term strategies that respect these biological signals.

Accelerometer-derived measures of sleep duration and quality are heritable and genetically distinct from self-reported measures, with specific genetic variants (e.g., PDE11A, MEIS1) influencing sleep traits.

Use objective sleep tracking (accelerometers) to get a more accurate picture of your sleep genetics and quality, as self-reports may be biased. Focus on identifying specific sleep issues (duration, efficiency) rather than just feeling rested.

Traditional self-reported dietary instruments (diet recalls, diaries, FFQs) systematically underreport energy intake, with the magnitude of error increasing with BMI, thereby attenuating or reversing observed diet-disease relationships.

Do not rely on your memory of what you ate to calculate calories or track weight loss progress. Self-reported intake is consistently 16-30% lower than actual intake, especially if you are overweight. For accurate health insights, use objective biomarkers (like Doubly Labeled Water) or calibrated statistical corrections rather than self-reported food diaries.

Obesity causes hypertension through multiple mechanisms including SNS overactivation, RAAS stimulation, leptin resistance, insulin resistance, and mechanical renal compression.

High blood pressure in obese individuals is not just about volume; it's driven by overactive nerves, hormones like leptin and insulin, and physical pressure on the kidneys. Treating the obesity addresses these root causes.

Across all populations, antihypertensive medications achieve greater systolic blood pressure (SBP) reductions than structured exercise interventions, with a mean difference of -3.96 mmHg.

Structured exercise lowers blood pressure, but not as much as medication. If you have hypertension, do not rely on exercise alone to manage it; consult your doctor about medication. Exercise is a valuable adjunct, but medication provides a stronger effect.